Expanding the Role of Suprachoroidal Injections - Summary - MDSpire

Expanding the Role of Suprachoroidal Injections

Clinical data support this targeted route for small molecules, gene therapy, and oncologic agents, with a good safety profile and potential to reduce treatment burden.

  • By

  • Thomas A. Ciulla, MD, MBA

  • September 1, 2025

  • 18 min

Share

Objective:

To explore the advancements and clinical implications of suprachoroidal drug delivery in ophthalmology, emphasizing its significance in improving treatment outcomes.

Approach:
    Key Findings:
    • Suprachoroidal administration offers a good safety profile and potential for sustained drug delivery, with implications for various ocular conditions.
    • The FDA approved Xipere for suprachoroidal use, marking a significant milestone in ocular therapeutics and paving the way for future innovations.
    • Suprachoroidal injections achieve durable drug levels in targeted tissues while limiting anterior-segment exposure, addressing limitations of traditional delivery methods.
    Interpretation:

    The suprachoroidal route represents a paradigm shift in ocular drug delivery, addressing limitations of traditional methods and enhancing therapeutic efficacy, particularly for macular disorders.

    Limitations:
    • Further clinical studies are needed to fully establish long-term safety and efficacy, particularly in diverse patient populations.
    • The technology may require specialized training for proper administration, which could limit widespread adoption.
    Conclusion:

    Suprachoroidal injections are poised to revolutionize ocular drug delivery, offering targeted treatment options with reduced systemic side effects, though challenges in training and implementation remain.

Original Source(s)

Expanding the Role of Suprachoroidal Injections

  • by Thomas A. Ciulla, MD, MBA

  • September 1, 2025

Related Content

Expanding Imaging Capabilities

Optos’ new Silverstone platform seeks to narrow the gap between visualization and structural insight in retinal imaging

  • June 1, 2026

  • 3 min
Tattoo-Associated Uveitis: What Primary Eye Care Needs to Know in 2026

Drs. Cass and Wolfe review recent research on tattoo-associated uveitis and offer practcal takeaways in uveitis cases.

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort